A- A A+

Early Diagnosis of Hearing Loss in Patients Under Methadone Maintenance Treatment.

Bayat A, Saki N, Mirmomeni G, Yadollahpour A.

Front Neurol. 2019 Jul 16;10:749. doi: 10.3389/fneur.2019.00749. 

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646465/

Dose Tapering Strategy for Heroin Abstinence among Methadone Maintenance Treatment Participants: Evidence from A Retrospective Study in Guangdong, China.

Lu Q, Zou X, Liu Y, Gong C, Ling L.

Int J Environ Res Public Health. 2019 Aug 6;16(15). pii: E2800. doi: 10.3390/ijerph16152800.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695604/

Frequent nightmares in Chinese patients undergoing methadone maintenance therapy: prevalence, correlates, and their association with functional impairment.

Zhong BL, Xu YM, Xie WX, Lu J.

Neuropsychiatr Dis Treat. 2019 Jul 18;15:2063-2072. doi: 10.2147/NDT.S202813. 

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646172/

Efficacy of Electroacupuncture Combined with Methadone Maintenance Therapy: A Case-Control Study.

Chen YL, Lee TC, Chen YT, Lo LC, Hsu WY, Ouyang WC.

Evid Based Complement Alternat Med. 2019 Jul 21;2019:7032581. doi: 10.1155/2019/7032581. 

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6699302/

Retrospective analysis reveals significant association of hypoglycemia with tramadol and methadone in contrast to other opioids.

Makunts T, U A, Atayee RS, Abagyan R.

Sci Rep. 2019 Aug 28;9(1):12490. doi: 10.1038/s41598-019-48955-y.

https://www.nature.com/articles/s41598-019-48955-y

Tramadol könnte Hypoglykämien auslösen

San Diego – Das Schmerzmittel Tramadol, das zunehmend als sichere Alternative zu anderen Opioiden betrachtet wird, kann offenbar schwere Hypoglykämien auslösen. Dies kam in einer Analyse von Datenbanken der US-Arzneimittelbehörde FDA in Scientific Reports(2019; 9: 12490) heraus. (aerzteblatt.de, 29.08.2019)

https://www.aerzteblatt.de/nachrichten/105626/Tramadol-koennte-Hypoglykaemien-ausloesen

Transitioning Hospitalized Patients with Opioid Use Disorder from Methadone to Buprenorphine without a Period of Opioid Abstinence Using a Microdosing Protocol.

Terasaki D, Smith C, Calcaterra SL.

Pharmacotherapy. 2019 Jul 26. doi: 10.1002/phar.2313.

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/31348544

Specificity of personality relationships to particular forms of concurrent substance use among methadone maintenance therapy clients.

Mahu IT, Conrod PJ, Barrett SP, Sako A, Swansburg J, Lawrence M, Laroque F, Morin JF, Chinneck A, Nogueira-Arjona R, Stewart SH.

Addict Behav. 2019 Jul 17;98:106056. doi: 10.1016/j.addbeh.2019.106056.

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/31351326

Decreased Level of Blood MicroRNA-133b in Men with Opioid Use Disorder on Methadone Maintenance Therapy.

Hsu CW, Huang TL, Tsai MC.

J Clin Med. 2019 Jul 25;8(8). pii: E1105. doi: 10.3390/jcm8081105.

https://www.mdpi.com/2077-0383/8/8/1105

Comparing the Effects of Methadone, Buprenorphine, and Opium Tincture Maintenance Therapy on Sexual Function.

Kheradmand A, Fazeli A, Mazaheri Meybodi A.

Addict Health. 2019 Apr;11(2):120-128. doi: 10.22122/ahj.v11i2.232.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6633070/

Effectiveness of Mindfulness-based Relapse Prevention on Quality of Life and Craving in Methadone-treated Patients: A Randomized Clinical Trial.

Yaghubi M, Zargar F.

Addict Health. 2018 Oct;10(4):250-259. doi: 10.22122/ahj.v10i4.573.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593172/

Exploring the Effects of Vitamin D Supplementation on Cognitive Functions and Mental Health Status in Subjects Under Methadone Maintenance Treatment.

Ghaderi A, Rasouli-Azad M, Farhadi MH, Mirhosseini N, Motmaen M, Pishyareh E, Omidi A, Asemi Z.

J Addict Med. 2019 May 24. doi: 10.1097/ADM.0000000000000550. 

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/31145174

Cigarette Smoking Is Significantly Linked to Sexual Dissatisfaction in Chinese Heroin-Dependent Patients Receiving Methadone Maintenance Treatment.

Zhong BL, Xu YM, Xie WX, Lu J.

Front Psychiatry. 2019 May 22;10:306. doi: 10.3389/fpsyt.2019.00306.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6538806/

Loneliness and Illicit Opioid Use Among Methadone Maintenance Treatment Patients.

Polenick CA, Cotton BP, Bryson WC, Birditt KS.

Subst Use Misuse. 2019 Jun 24:1-10. doi: 10.1080/10826084.2019.1628276. 

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/31232142

Functional Correlates of Resting-State Connectivity in the Default Mode Network of Heroin Users on Methadone Treatment and Medication-Free Therapeutic Community Program.

Kuo LW, Lin PS, Lin SY, Liu MF, Jan H, Lee HC, Wang SC.

Front Psychiatry. 2019 Jun 6;10:381. doi: 10.3389/fpsyt.2019.00381. 

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562277/

Double-Blind Placebo-Controlled Trial of Galantamine for Methadone-Maintained Individuals With Cocaine Use Disorder: Secondary Analysis of Effects on Illicit Opioid Use.

Carroll KM, DeVito EE, Yip SW, Nich C, Sofuoglu M.

Am J Addict. 2019 Jun 4. doi: 10.1111/ajad.12904.

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/31165574

Ginseng treatment improves the sexual side effects of methadone maintenance treatment.

Farnia V, Alikhani M, Ebrahimi A, Golshani S, Sadeghi Bahmani D, Brand S.

Psychiatry Res. 2019 May 2;276:142-150. doi: 10.1016/j.psychres.2019.05.004. 

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/31082749

Comparison of Sexual Function and Serum Testosterone Levels in Men Opiate Addicts, under Methadone Maintenance Therapy, and Healthy Men.

Agha-Mohammadhasani P, Mokhtaree M, Nazari A, Rahnama A.

Addict Health. 2018 Apr;10(2):76-85. doi: 10.22122/ahj.v10i2.540.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494984/

Craving for heroin: difference between methadone maintenance therapy patients with and without ADHD.

Coppola M, Sacchetto G, Mondola R.

Trends Psychiatry Psychother. 2019 Jan-Mar;41(1):83-86. doi: 10.1590/2237-6089-2017-0159.

http://www.scielo.br/pdf/trends/v41n1/2238-0019-trends-41-01-0083.pdf

Characterization of the Safety and Pharmacokinetic Profile of D-Methadone, a Novel N-Methyl-D-Aspartate Receptor Antagonist in Healthy, Opioid-Naive Subjects: Results of Two Phase 1 Studies.

Bernstein G, Davis K, Mills C, Wang L, McDonnell M, Oldenhof J, Inturrisi C, Manfredi PL, Vitolo OV.

J Clin Psychopharmacol. 2019 May/Jun;39(3):226-237. doi: 10.1097/JCP.0000000000001035.

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/30939592

Rapid transition from methadone to buprenorphine using naltrexone-induced withdrawal: A case report.

Ward HB, Barnett BS, Suzuki J.

Subst Abus. 2019 Mar 19:1-6. doi: 10.1080/08897077.2019.1573776.

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/30888254

Relevance of CYP2B6 and CYP2D6 genotypes to methadone pharmacokinetics and response in the OPAL study.

Victorri-Vigneau C, Verstuyft C, Bouquié R, Laforgue EJ, Hardouin JB, Leboucher J, Le Geay B, Dano C, Challet-Bouju G, Grall-Bronnec M.

Br J Clin Pharmacol. 2019 Mar 25. doi: 10.1111/bcp.13936. 

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/30907440

A Pilot Crossover Trial of Sleep Medications for Sleep-disturbed Methadone Maintenance Patients.

Stein MD, Kurth ME, Anderson BJ, Blevins CE.

J Addict Med. 2019 Mar 9. doi: 10.1097/ADM.0000000000000531. 

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/30870203

Effects of Methadone Maintenance Therapy on Thyroid Function of Adult Men.

Bozchelou S, Delirrad M.

Toxicol Res. 2019 Jan;35(1):9-12. doi: 10.5487/TR.2019.35.1.009. 

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354949/

Initiation and Rapid Titration of Methadone in an Acute Care Setting for the Treatment of Opioid Use Disorder: A Case Report.

Hemmons P, Bach P, Colizza K, Nolan S.

J Addict Med. 2019 Feb 5. doi: 10.1097/ADM.0000000000000507.

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/30741835

Comparing opium tincture and methadone for medication-assisted treatment of patients with opioid use disorder: Protocol for a multicenter parallel group noninferiority double-blind randomized controlled trial.

Nikoo M, Moazen-Zadeh E, Nikoo N, Javidanbardan S, Kazemi A, Choi F, Vogel M, Gholami A, Tavakoli S, Givaki R, Jazani M, Mohammadian F, Markazi Moghaddam N, Goudarzi N, Schutz C, Jang K, Akhondzadeh S, Krausz M.

Int J Methods Psychiatr Res. 2019 Feb 4:e1768. doi: 10.1002/mpr.1768. 

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/30714249

Intravenous Misuse of Methadone, Buprenorphine and Buprenorphine-Naloxone in Patients Under Opioid Maintenance Treatment: A Cross-Sectional Multicentre Study.

Lugoboni F, Zamboni L, Cibin M, Tamburin S; Gruppo InterSERT di Collaborazione Scientifica (GICS).

Eur Addict Res. 2019;25(1):10-19. doi: 10.1159/000496112. 

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/30625491

Methadone Safety: A Clinical Practice Guideline From the American Pain Society and College on Problems of Drug Dependence, in Collaboration With the Heart Rhythm Society

Chou, Roger et al.

The Journal of Pain , Volume 15 , Issue 4 , 321 - 337 

https://www.jpain.org/article/S1526-5900(14)00522-7/fulltext

Methadone therapy modulate the dendritic cells of heroin addicts.

Akbari A, Mosayebi G, Samiei AR, Ghazavi A.

Int Immunopharmacol. 2019 Jan;66:330-335. doi: 10.1016/j.intimp.2018.11.047.

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/30521961

Safe and Appropriate Use of Methadone in Hospice and Palliative Care: Expert Consensus White Paper.

McPherson ML, Walker KA, Davis MP, Bruera E, Reddy A, Paice J, Malotte K, Lockman DK, Wellman C, Salpeter S, Bemben NM, Ray JB, Lapointe BJ, Chou R.

J Pain Symptom Manage. 2018 Dec 19. pii: S0885-3924(18)31114-X. doi: 10.1016/j.jpainsymman.2018.12.001.

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/30578934